

About
We provide mass spectrometry services for internal and external clients. Currently we support exclusively proteomics services for the identification and relative quantitation of proteins.
Expertises and services
Let us enhance your research
We offer proteomics services to internal and external clients and are also open to collaborative research projects.
read moreLet us enhance your research
Mass spectrometry is a powerful analytical technique that measures the mass of ionized molecules for identification and quantization in simple and complex mixtures.
We offer proteomics services to internal and external clients. Our current service offers identification and label-free quantitation of up to up to 8000 proteins in client samples using a standardized proteomics workflow on our timsTOF Pro2 instruments using the Spectronaut software.
We are also open to collaborative research projects that are aligned with the internal focus and expertise of the technology center. Please use the contact form at the top of our RTC page if you would like to discuss possibilities.
Proteomics services and sample submission
Overview of our services, and the steps and guidelines on sample submission.
read moreProjects
Overview of key projects at our technology center.
-
NWO National Roadmap Large-Scale Research Infrastructure roadmap project combining technologies in the field of genomics, proteomics, metabolomics and data analysis, integration & stewardship (2018-2029).
More information can be found on this website.
-
Public-private partnership project to develop glycan database free glycoproteomics software solutions (2025-2028).
-
Health-Holland public-private partnership project to develop real-time data processing solutions for implementation of (glyco)proteomics technology in clinical environments (2021-2025).
-
Stofwisselkracht project to establish multi omics readout platform for patient derived 3D engineered heart tissues (2023-2025).
-
United for Metabolic Disease project to establish a multi omics platform for inborn errors of metabolism biomarker discovery (2020-2024).
-
ZonMw medium investment project to establish (pre-)clinical glycoproteomics platform (2019-2023).